Back to Search
Start Over
Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure
- Source :
- JACC: Heart Failure; November 2023, Vol. 11 Issue: 11 p1507-1517, 11p
- Publication Year :
- 2023
-
Abstract
- Polypharmacy is common among patients with heart failure with reduced ejection fraction (HFrEF). However, its impact on the use of optimal guideline-directed medical therapy (GDMT) is not well established.
Details
- Language :
- English
- ISSN :
- 22131779
- Volume :
- 11
- Issue :
- 11
- Database :
- Supplemental Index
- Journal :
- JACC: Heart Failure
- Publication Type :
- Periodical
- Accession number :
- ejs64384235
- Full Text :
- https://doi.org/10.1016/j.jchf.2023.03.007